Luciana Martins Rozman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luciana Martins Rozman has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Patrícia Coelho de Soárez
Universidade de São Paulo, Brazil
7 shared publications - Ana Marli Christovam Sartori
Universidade de São Paulo
4 shared publications Alessandro Gonçalves Campolina
Center for Translational Research in Oncology, São Paulo State Cancer Institute, São Paulo, Brazil
3 shared publications- Alexandra Azevedo Souza
Secretaria Municipal de Saúde de Cubatão, Brazil
2 shared publications - Rossana Verónica Mendoza López
Cancer Institute of the State of São Paulo, Brazil
2 shared publications Toshio Chiba
Universidade de Sao Paulo Faculdade de Medicina Hospital das Clinicas Instituto do Cancer, Sao Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
Cost-consequence analysis of surgical and clinical treatment modalities of laryngeal cancer
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 34
Descompasso entre registros oficiais do Sistema de Informações do Programa Nacional de Imunizações e inquérito domiciliar de cobertura vacinal em Cubatão, São Paulo: estudo transversal, 2023
Resumo Objetivo Avaliar a concordância entre os dados de vacinação registrados no Sistema de Informações do Programa Nacional de Imunizações e as informações nas cadernetas de vacinação de crianças menores de 2 anos que participaram do inquérito domiciliar de cobertura vacinal em Cubatão, São Paulo. Métodos Trata-se de estudo descritivo comparando as doses registradas nas cadernetas de vacinação com as do Sistema de Informações do Programa Nacional de Imunizações para crianças nascidas em 2019 e 2020. A concordância foi avaliada quanto ao registro das doses aplicadas e das datas de aplicação, utilizando o teste de Kappa e o coeficiente de correlação intraclasse. Resultados O inquérito domiciliar mostrou que as metas de cobertura vacinal foram atingidas para todas as vacinas do calendário nacional de imunização para menores de 2 anos: 90,0% para BCG e rotavírus humano, e 95,0% para as demais vacinas. Ao verificar as mesmas crianças no sistema de informações, a cobertura ficou abaixo de 70,0%, e em 10,0% delas as datas de aplicação eram discordantes. Cerca de 24,0% das crianças não possuíam registro no sistema de informações, apesar de terem as vacinas registradas nas cadernetas. Conclusão Os resultados indicam problemas na precisão e completude dos dados do Sistema de Informações do Programa Nacional de Imunizações em comparação com as cadernetas de vacinação, evidenciando desafios no registro de vacinação que podem comprometer o monitoramento das coberturas vacinais em Cubatão.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 34
Open AccessDescompasso entre registros oficiais do Sistema de Informações do Programa Nacional de Imunizações e inquérito domiciliar de cobertura vacinal em Cubatão, São Paulo: estudo transversal, 2023
Resumo Objetivo Avaliar a concordância entre os dados de vacinação registrados no Sistema de Informações do Programa Nacional de Imunizações e as informações nas cadernetas de vacinação de crianças menores de 2 anos que participaram do inquérito domiciliar de cobertura vacinal em Cubatão, São Paulo. Métodos Trata-se de estudo descritivo comparando as doses registradas nas cadernetas de vacinação com as do Sistema de Informações do Programa Nacional de Imunizações para crianças nascidas em 2019 e 2020. A concordância foi avaliada quanto ao registro das doses aplicadas e das datas de aplicação, utilizando o teste de Kappa e o coeficiente de correlação intraclasse. Resultados O inquérito domiciliar mostrou que as metas de cobertura vacinal foram atingidas para todas as vacinas do calendário nacional de imunização para menores de 2 anos: 90,0% para BCG e rotavírus humano, e 95,0% para as demais vacinas. Ao verificar as mesmas crianças no sistema de informações, a cobertura ficou abaixo de 70,0%, e em 10,0% delas as datas de aplicação eram discordantes. Cerca de 24,0% das crianças não possuíam registro no sistema de informações, apesar de terem as vacinas registradas nas cadernetas. Conclusão Os resultados indicam problemas na precisão e completude dos dados do Sistema de Informações do Programa Nacional de Imunizações em comparação com as cadernetas de vacinação, evidenciando desafios no registro de vacinação que podem comprometer o monitoramento das coberturas vacinais em Cubatão.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 34, e20240523
Discrepancy between official records of the Brazilian National Immunization Program Information System and the household survey about vaccination coverage in Cubatão, São Paulo: cross-sectional study, 2023
Objective To assess the concordance between vaccination data registered in the Brazilian National Immunization Program Information System and information in the vaccination booklets of children under 2 years of age who participated in the household survey of vaccination coverage in Cubatão, São Paulo. Methods This is a descriptive study comparing the doses registered in vaccination booklets with those in the Brazilian National Immunization Program Information System for children born in 2019 and 2020. Concordance was assessed regarding the doses applied and application dates recorded, using the Kappa test and the intraclass correlation coefficient. Results The household survey showed that vaccination coverage targets were achieved for all vaccines in the national immunization schedule for children under 2 years of age: 90.0% for BCG and human rotavirus, and 95.0% for other vaccines. When checking the same children in the information system, coverage was below 70.0%, and in 10.0% of them the application dates were inconsistent. Approximately 24.0% of the children were not entered in the information system, despite having their vaccinations recorded in their booklets. Conclusion The results indicate issues regarding accuracy and completeness of data from the Brazilian National Immunization Program Information System compared to vaccination booklets, highlighting challenges in vaccination records that may compromise monitoring of vaccination coverage in Cubatão.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 34, e20240523
Open AccessDiscrepancy between official records of the Brazilian National Immunization Program Information System and the household survey about vaccination coverage in Cubatão, São Paulo: cross-sectional study, 2023
Objective To assess the concordance between vaccination data registered in the Brazilian National Immunization Program Information System and information in the vaccination booklets of children under 2 years of age who participated in the household survey of vaccination coverage in Cubatão, São Paulo. Methods This is a descriptive study comparing the doses registered in vaccination booklets with those in the Brazilian National Immunization Program Information System for children born in 2019 and 2020. Concordance was assessed regarding the doses applied and application dates recorded, using the Kappa test and the intraclass correlation coefficient. Results The household survey showed that vaccination coverage targets were achieved for all vaccines in the national immunization schedule for children under 2 years of age: 90.0% for BCG and human rotavirus, and 95.0% for other vaccines. When checking the same children in the information system, coverage was below 70.0%, and in 10.0% of them the application dates were inconsistent. Approximately 24.0% of the children were not entered in the information system, despite having their vaccinations recorded in their booklets. Conclusion The results indicate issues regarding accuracy and completeness of data from the Brazilian National Immunization Program Information System compared to vaccination booklets, highlighting challenges in vaccination records that may compromise monitoring of vaccination coverage in Cubatão.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 41 (4) , e00089524
Cobertura e atraso vacinal nas coortes de nascidos em 2019 e 2020: inquérito domiciliar em Cubatão, Estado de São Paulo, Brasil
Resumo: O Programa Nacional de Imunizações tem enfrentado recentemente a redução no alcance das metas preconizadas de cobertura vacinal para as vacinas constantes do calendário nacional infantil. Em Cubatão, município do Estado de São Paulo, os dados oficiais do Sistema de Informações do Programa Nacional de Imunizações apontam que a cobertura vacinal em crianças apresentou declínio acentuado. O objetivo deste estudo foi estimar a real cobertura vacinal em menores de 2 anos, avaliar se as doses estão sendo aplicadas em momento oportuno e identificar fatores associados ao atraso vacinal por meio de inquérito domiciliar em residentes de Cubatão nascidos em 2019 e 2020. O município foi dividido em cinco estratos socioeconômicos, e o tamanho da amostra foi de 450 crianças. A cobertura vacinal aos 12 meses foi de 86,9%; e aos 24 meses, de 82,6%. Para o esquema vacinal completo, apenas 25,7% das crianças foram vacinadas sem atraso. Entre os fatores associados ao atraso vacinal aos 24 meses estão escolaridade da mãe e receber benefício do Bolsa Família. Embora a cobertura vacinal seja maior do que a observada no inquérito nacional, o atraso para aplicação das doses é um problema de saúde pública em Cubatão, o que exige educação dos profissionais de saúde da ponta e da população sobre a importância da vacinação em tempo oportuno.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 41 (4) , e00089524
Open AccessCobertura e atraso vacinal nas coortes de nascidos em 2019 e 2020: inquérito domiciliar em Cubatão, Estado de São Paulo, Brasil
Resumo: O Programa Nacional de Imunizações tem enfrentado recentemente a redução no alcance das metas preconizadas de cobertura vacinal para as vacinas constantes do calendário nacional infantil. Em Cubatão, município do Estado de São Paulo, os dados oficiais do Sistema de Informações do Programa Nacional de Imunizações apontam que a cobertura vacinal em crianças apresentou declínio acentuado. O objetivo deste estudo foi estimar a real cobertura vacinal em menores de 2 anos, avaliar se as doses estão sendo aplicadas em momento oportuno e identificar fatores associados ao atraso vacinal por meio de inquérito domiciliar em residentes de Cubatão nascidos em 2019 e 2020. O município foi dividido em cinco estratos socioeconômicos, e o tamanho da amostra foi de 450 crianças. A cobertura vacinal aos 12 meses foi de 86,9%; e aos 24 meses, de 82,6%. Para o esquema vacinal completo, apenas 25,7% das crianças foram vacinadas sem atraso. Entre os fatores associados ao atraso vacinal aos 24 meses estão escolaridade da mãe e receber benefício do Bolsa Família. Embora a cobertura vacinal seja maior do que a observada no inquérito nacional, o atraso para aplicação das doses é um problema de saúde pública em Cubatão, o que exige educação dos profissionais de saúde da ponta e da população sobre a importância da vacinação em tempo oportuno.
- Open Access
- 16 January 2023
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 21 (1) , 1-13
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Background: Stereotactic ablative radiotherapy (SABR) is recommended as first-choice treatment to inoperable early-stage non-small cell lung cancer (NSCLC). However, it is not widely adopted in developing countries, and its cost-effectiveness is unclear. We aimed to perform a systematic review of full economic evaluations (EE) that compared SABR with other radiotherapy or surgical procedures to assess the results and methodological approach. Methods: The protocol was registered on PROSPERO (CRD42021241640). We included full EE studies with early-stage NSCLC in which one group was submitted to SABR. Studies that were partial EE, included advanced NSCLC or other neoplasm were excluded. We performed the last search on June 2021 in Medline, EMBASE and other databases. The reporting quality were assessed by CHEERS checklist. The main characteristics of each study were tabulated, and the results were presented by a narrative synthesis. Results: We included nine studies. Three compared radiotherapy techniques, in which SABR was found to be dominant or cost-effective. Six compared SABR with surgery, and in this group, there was not a unanimous decision. All included only direct healthcare costs but varied about categories included. The parameters used in the model-based studies were highly heterogeneous using mixed data from various sources. The items properly reported varied from 29 to 67%. Conclusions: The studies were all from developed countries and lacked in reporting quality. We recommend that developing countries produce their own studies. More strict alignment to reporting guidelines and use of robust evidence as model parameters are also advised.
- 16 January 2023
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 21 (1) , 1-13
Open AccessSystematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Background: Stereotactic ablative radiotherapy (SABR) is recommended as first-choice treatment to inoperable early-stage non-small cell lung cancer (NSCLC). However, it is not widely adopted in developing countries, and its cost-effectiveness is unclear. We aimed to perform a systematic review of full economic evaluations (EE) that compared SABR with other radiotherapy or surgical procedures to assess the results and methodological approach. Methods: The protocol was registered on PROSPERO (CRD42021241640). We included full EE studies with early-stage NSCLC in which one group was submitted to SABR. Studies that were partial EE, included advanced NSCLC or other neoplasm were excluded. We performed the last search on June 2021 in Medline, EMBASE and other databases. The reporting quality were assessed by CHEERS checklist. The main characteristics of each study were tabulated, and the results were presented by a narrative synthesis. Results: We included nine studies. Three compared radiotherapy techniques, in which SABR was found to be dominant or cost-effective. Six compared SABR with surgery, and in this group, there was not a unanimous decision. All included only direct healthcare costs but varied about categories included. The parameters used in the model-based studies were highly heterogeneous using mixed data from various sources. The items properly reported varied from 29 to 67%. Conclusions: The studies were all from developed countries and lacked in reporting quality. We recommend that developing countries produce their own studies. More strict alignment to reporting guidelines and use of robust evidence as model parameters are also advised.
- 20 September 2021
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 24 (10) , 1481-1488
Factors Associated with the Costs of Palliative Care: A Retrospective Cost Analysis at a University Cancer Hospital in Brazil
Background: There have been few studies evaluating the costs of palliative care (PC) in low- and middle-income countries (LMICs), especially for patients with cancer. Objectives: The objective of this study was to identify the sociodemographic and clinical variables that could explain the cost per day of PC for cancer in Brazil. Methods: This was a retrospective cost analysis of PC at a quaternary cancer center in São Paulo, Brazil, between January 2010 and December 2013. Factors influencing the cost per day were assessed with generalized linear models and generalized linear-mixed models in which the random effect was the site of the cancer. Results: The study included 2985 patients. The mean total cost per patient was $12,335 (standard deviation [SD] = 14,602; 95% confidence interval [CI] = 11,803 to 12,851). The mean cost per day per patient was $325.50 (SD = 246.30, 95% CI = 316.60 to 334.30). There were statistically significant differences among cancer sites in terms of the mean cost per day. Multivariate analysis revealed that the drivers of cost per day were Karnofsky performance status, the number of hospital admissions, referral to PC, and place of death. Place of death had the greatest impact on the cost per day; death in a hospital and in hospice care increased the mean cost per day by $1.56 and $1.83, respectively. Conclusion: To allocate resources effectively, PC centers in LMICs should emphasize early enrollment of patients at PC outpatient clinics, to avoid hospital readmission, as well as advance planning of the place of death.
- 20 September 2021
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 24 (10) , 1481-1488
Factors Associated with the Costs of Palliative Care: A Retrospective Cost Analysis at a University Cancer Hospital in Brazil
Background: There have been few studies evaluating the costs of palliative care (PC) in low- and middle-income countries (LMICs), especially for patients with cancer. Objectives: The objective of this study was to identify the sociodemographic and clinical variables that could explain the cost per day of PC for cancer in Brazil. Methods: This was a retrospective cost analysis of PC at a quaternary cancer center in São Paulo, Brazil, between January 2010 and December 2013. Factors influencing the cost per day were assessed with generalized linear models and generalized linear-mixed models in which the random effect was the site of the cancer. Results: The study included 2985 patients. The mean total cost per patient was $12,335 (standard deviation [SD] = 14,602; 95% confidence interval [CI] = 11,803 to 12,851). The mean cost per day per patient was $325.50 (SD = 246.30, 95% CI = 316.60 to 334.30). There were statistically significant differences among cancer sites in terms of the mean cost per day. Multivariate analysis revealed that the drivers of cost per day were Karnofsky performance status, the number of hospital admissions, referral to PC, and place of death. Place of death had the greatest impact on the cost per day; death in a hospital and in hospice care increased the mean cost per day by $1.56 and $1.83, respectively. Conclusion: To allocate resources effectively, PC centers in LMICs should emphasize early enrollment of patients at PC outpatient clinics, to avoid hospital readmission, as well as advance planning of the place of death.
- 15 October 2019
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 12 (e2) , e211-e218
Palliative cancer care: costs in a Brazilian quaternary hospital
Palliative care (PC) improves the quality of life of patients with diseases such as cancer, and several studies have shown a reduction in costs among patients who use PC services when compared with those receiving standard oncological treatments. Most studies on PC costs are carried out in high-income countries. There is a lack of these types of studies in middle-income and low-income countries and of better evidence about this intervention. Objective To describe resource utilisation and costs among patients with cancer in a Brazilian quaternary hospital by cancer localisation and per month of treatment before death. Methods This study is a description of retrospective costs to estimate the costs of formal healthcare sector associated with PCs, from the perspective of a public quaternary cancer hospital. Unit costs were estimated using microcosting and macrocosting approaches. Setting/Participants Patients older than 18 years old who died from 2010 to 2013 and who had at least two visits in PC and/or made use of hospice care. Results Among the 2985 patients included in the study, the average cost per patient was US$12 335, ranging from US$8269 for patients with pancreatic cancer to US$19 395 for patients with brain cancer. The main costing item was hospital admission (47.6% of the total cost), followed by hospice care (29.5%) and medical and other supplies (11.1%). Conclusions The study clarified the direct medical costs and the profile and use of resources of patients with cancer who need PC, and can help in the planning and allocation of resources in cancer care.
- 15 October 2019
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 12 (e2) , e211-e218
Palliative cancer care: costs in a Brazilian quaternary hospital
Palliative care (PC) improves the quality of life of patients with diseases such as cancer, and several studies have shown a reduction in costs among patients who use PC services when compared with those receiving standard oncological treatments. Most studies on PC costs are carried out in high-income countries. There is a lack of these types of studies in middle-income and low-income countries and of better evidence about this intervention. Objective To describe resource utilisation and costs among patients with cancer in a Brazilian quaternary hospital by cancer localisation and per month of treatment before death. Methods This study is a description of retrospective costs to estimate the costs of formal healthcare sector associated with PCs, from the perspective of a public quaternary cancer hospital. Unit costs were estimated using microcosting and macrocosting approaches. Setting/Participants Patients older than 18 years old who died from 2010 to 2013 and who had at least two visits in PC and/or made use of hospice care. Results Among the 2985 patients included in the study, the average cost per patient was US$12 335, ranging from US$8269 for patients with pancreatic cancer to US$19 395 for patients with brain cancer. The main costing item was hospital admission (47.6% of the total cost), followed by hospice care (29.5%) and medical and other supplies (11.1%). Conclusions The study clarified the direct medical costs and the profile and use of resources of patients with cancer who need PC, and can help in the planning and allocation of resources in cancer care.
- 1 May 2018
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 21 (5) , 659-664
Early Palliative Care and Its Impact on End-of-Life Care for Cancer Patients in Brazil
Background: Integrating palliative care into standard oncology care has been recommended for cancer patients. Early palliative care is associated with less aggressive treatment at the end of life. Objective: To describe cancer patients receiving palliative care in Brazil, determining the time from entry into palliative care to death, and investigating whether late referral to palliative care is associated with aggressive end-of-life treatment. Design: This was a cross-sectional study of cancer patients receiving palliative care in Brazil. Setting/Subjects: Subjects were 2985 cancer patients ≥18 years of age who received at least two palliative care visits at the São Paulo State Cancer Institute, in the city of São Paulo, Brazil, and died between 2010 and 2013. Measurements: We evaluated the time from the first palliative care consult to death, stratifying cases by the timing of entry into palliative care (≥3 or Results: The overall median time between entry into palliative care and death was 34 days (mean, 72 days) and was significantly shorter in 2013 than in 2010 (p < 0.001). The number of emergency department visits was significantly lower among the patients who entered palliative care earlier (p < 0.001). Conclusions: Among cancer patients in Brazil, late referral to palliative care is common. Patients who enter palliative care earlier appear to receive less aggressive end-of-life treatment.
- 1 May 2018
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 21 (5) , 659-664
Early Palliative Care and Its Impact on End-of-Life Care for Cancer Patients in Brazil
Background: Integrating palliative care into standard oncology care has been recommended for cancer patients. Early palliative care is associated with less aggressive treatment at the end of life. Objective: To describe cancer patients receiving palliative care in Brazil, determining the time from entry into palliative care to death, and investigating whether late referral to palliative care is associated with aggressive end-of-life treatment. Design: This was a cross-sectional study of cancer patients receiving palliative care in Brazil. Setting/Subjects: Subjects were 2985 cancer patients ≥18 years of age who received at least two palliative care visits at the São Paulo State Cancer Institute, in the city of São Paulo, Brazil, and died between 2010 and 2013. Measurements: We evaluated the time from the first palliative care consult to death, stratifying cases by the timing of entry into palliative care (≥3 or Results: The overall median time between entry into palliative care and death was 34 days (mean, 72 days) and was significantly shorter in 2013 than in 2010 (p < 0.001). The number of emergency department visits was significantly lower among the patients who entered palliative care earlier (p < 0.001). Conclusions: Among cancer patients in Brazil, late referral to palliative care is common. Patients who enter palliative care earlier appear to receive less aggressive end-of-life treatment.
- Open Access
- 10 March 2017
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 13 (6) , 1454-1465
A systematic review of health economic evaluations of vaccines in Brazil
Background: In Brazil, since 2005, the Ministry of Health requires Health Economic Evaluation (HEE) of vaccines for introduction into the National Immunization Program. Objectives: To describe and analyze the full HEE on vaccines conducted in Brazil from 1980 to 2013. Methods: Systematic review of the literature. We searched multiple databases. Two researchers independently selected the studies and extracted the data. The methodological quality of individual studies was evaluated using CHEERS items. Results: Twenty studies were reviewed. The most evaluated vaccines were pneumococcal (25%) and HPV (15%). The most used types of HEE were cost-effectiveness analysis (45%) and cost-utility analysis (20%). The research question and compared strategies were stated in all 20 studies and the target population was clear in 95%. Nevertheless, many studies did not inform the perspective of analysis or data sources. Conclusions: HEE of vaccines in Brazil has increased since 2008. However, the studies still have methodological deficiencies.
- 10 March 2017
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 13 (6) , 1454-1465
Open AccessA systematic review of health economic evaluations of vaccines in Brazil
Background: In Brazil, since 2005, the Ministry of Health requires Health Economic Evaluation (HEE) of vaccines for introduction into the National Immunization Program. Objectives: To describe and analyze the full HEE on vaccines conducted in Brazil from 1980 to 2013. Methods: Systematic review of the literature. We searched multiple databases. Two researchers independently selected the studies and extracted the data. The methodological quality of individual studies was evaluated using CHEERS items. Results: Twenty studies were reviewed. The most evaluated vaccines were pneumococcal (25%) and HPV (15%). The most used types of HEE were cost-effectiveness analysis (45%) and cost-utility analysis (20%). The research question and compared strategies were stated in all 20 studies and the target population was clear in 95%. Nevertheless, many studies did not inform the perspective of analysis or data sources. Conclusions: HEE of vaccines in Brazil has increased since 2008. However, the studies still have methodological deficiencies.
- Open Access
- 1 May 2007
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 23 (5) , 1051-1059
Resistência do Mycobacterium tuberculosis às drogas em pacientes HIV+ em cinco municípios da Baixada Santista, São Paulo, Brasil
No início dos anos 90, observou-se aumento da resistência do Mycobacterium tuberculosis às drogas antituberculose, com alta prevalência entre pacientes HIV+. Neste estudo, foram avaliados a freqüência de resistência, o perfil de sensibilidade do M. tuberculosis às drogas e os fatores predisponentes à resistência entre indivíduos HIV+ nos municípios de Santos, São Vicente, Cubatão, Praia Grande e Guarujá, Estado de São Paulo, Brasil. Foram pesquisados os prontuários de 301 pacientes com resultado de cultura positivo entre 1993 e 2003. A resistência ocorreu em 57 (18,9%) pacientes com a seguinte distribuição: 32 (10,6%) apresentaram tuberculose multirresistente (resistência ao menos à Rifampicina e Isoniazida); 4 (1,3%) casos apresentaram resistência a duas ou mais drogas e 21 (7%) à monorresistência. Observou-se resistência secundária em 70,2% dos casos. Estatisticamente associadas à tuberculose resistente foram: tratamento anterior com drogas antituberculose, tempo de diagnóstico de HIV e hospitalização prévia. Em análise multivariada, apenas tratamento anterior, ajustado por faixa etária, mostrou-se associado (OR = 5,49; IC95%: 2,60-11,60). A ocorrência de resistência em 18,9% dos casos e multirresistência em aproximadamente 10% confirmam a relevância deste problema entre pacientes HIV+ na Baixada Santista.
- 1 May 2007
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 23 (5) , 1051-1059
Open AccessResistência do Mycobacterium tuberculosis às drogas em pacientes HIV+ em cinco municípios da Baixada Santista, São Paulo, Brasil
No início dos anos 90, observou-se aumento da resistência do Mycobacterium tuberculosis às drogas antituberculose, com alta prevalência entre pacientes HIV+. Neste estudo, foram avaliados a freqüência de resistência, o perfil de sensibilidade do M. tuberculosis às drogas e os fatores predisponentes à resistência entre indivíduos HIV+ nos municípios de Santos, São Vicente, Cubatão, Praia Grande e Guarujá, Estado de São Paulo, Brasil. Foram pesquisados os prontuários de 301 pacientes com resultado de cultura positivo entre 1993 e 2003. A resistência ocorreu em 57 (18,9%) pacientes com a seguinte distribuição: 32 (10,6%) apresentaram tuberculose multirresistente (resistência ao menos à Rifampicina e Isoniazida); 4 (1,3%) casos apresentaram resistência a duas ou mais drogas e 21 (7%) à monorresistência. Observou-se resistência secundária em 70,2% dos casos. Estatisticamente associadas à tuberculose resistente foram: tratamento anterior com drogas antituberculose, tempo de diagnóstico de HIV e hospitalização prévia. Em análise multivariada, apenas tratamento anterior, ajustado por faixa etária, mostrou-se associado (OR = 5,49; IC95%: 2,60-11,60). A ocorrência de resistência em 18,9% dos casos e multirresistência em aproximadamente 10% confirmam a relevância deste problema entre pacientes HIV+ na Baixada Santista.